Craig Lindsey's Background
Dr. D. Craig Lindsey, MD, is a highly accomplished and board-certified Emergency Medicine specialist with a distinguished career spanning over three decades. Holding a re-certification in Emergency Medicine and specialized training in Wound Care and Hyperbaric Medicine, Dr. Lindsey has significantly contributed to the medical field through various roles and leadership positions.
Dr Lindsey is focusing full time on Long COVID treatment and issues surrounding access, as well as wound care education. He directs and runs Hyperbaric Wellness, LLC, an online resource to help Long COVID patients with diagnosis, testing and connection to affordable and safe HBO treatments.
Dr Lindsey recently retired from his position as the Medical Director at CHRISTUS St. Vincent Regional Wound and Hyperbaric Center in Santa Fe, NM, a position he has held since 2010. His expertise is further recognized in his role as an Assistant Clinical Professor at the University of New Mexico Hospital's Department of Emergency Medicine, where he has been shaping future medical professionals since 2003.
Dr. Lindsey’s professional journey is marked by notable positions, including Governance Council Chairman and elected representative for specialty services at CHRISTUS St. Vincent Medical Group. His commitment to education is evident through his past roles as Director of ER Resident Education and his ongoing involvement in resident education and clinical instruction in Wound and Hyperbaric Medicine.
In addition to his clinical and educational contributions, Dr. Lindsey has made significant strides in research, particularly in the fields of septic shock, pulmonary edema, and hypertonic saline solutions for resuscitation. His work has been published in several esteemed medical journals, underscoring his dedication to advancing medical knowledge.
Dr. Lindsey’s honors include membership in the Alpha Omega Alpha National Medical Honor Society and receiving the S. Oakley Vander Poel Prize for outstanding clinical exams from Albany Medical College. He also earned corporate recognition for outstanding scientific achievement from Bayer HealthCare and a citation for academic and research excellence from UC Davis.
Beyond his professional achievements, Dr. Lindsey enjoys mountain and road cycling, alpine skiing, and travel, which complement his dynamic and multifaceted career. His extensive experience, leadership, and dedication make him a pillar in the fields of emergency and hyperbaric medicine.
About Wound Reference
WoundReference is the only decision support platform designed exclusively for wound care and hyperbaric oxygen clinicians. Our point-of-care tools enable clinicians to work more efficiently.
-
HBO Treatment Emerging Indications
CLINICALOverviewBackgroundDefinitionsHBOT emerging indication: An HBOT (Hyperbaric Oxygen Therapy) emerging indication is a medical condition or therapeutic use being explored for potential benefit from HBOT but has not yet received formal approval or endorsement from authoritative organizations, such as the Undersea and Hyperbaric Medical Society (UHMS). These indications are supported by early clinical evidence and biological plausibility, suggesting t
-
HBO Treatment Emerging Indication: Long COVID
ABSTRACTHBO treatment of Long COVID is effective and safe. It remains the only effective treatment for this diagnosis that can reverse or improve many symptoms across all organ systems and the benefits are long lasting. The mechanisms by which this occurs remain unconfirmed but are thought to be related to the ability of HBO treatment to modulate inflammation, release stem cells from the bone marrow, affect the immune system and mitochondria and re
-
Beyond Clinical Evidence: Navigating the Barriers to HBOT in Long COVID Treatment
Executive SummaryHyperbaric oxygen therapy (HBOT) has emerged as an effective treatment for Long COVID, a condition affecting 10’s of millions of people in the US and characterized by persistent and debilitating symptoms following SARS-CoV-2 infection. This analysis explores the mechanisms and clinical evidence supporting the efficacy of HBOT in addressing the complex pathophysiology underlying Long COVID. The author also discusses the social and economic consequences of this new dis
